N-Nitroso N-Desmethyl Ivabradine
 
		Product Description
CAT No.
				
									ALN-I014066								
				CAS No.
				
									NA								
				Mol. F.
				
									C26H33N3O6								
				Mol. Wt.
				
									483.6								
				Stock
				
									Please Inquire								
				
										
							
										Product Overview
						
											
										
							
										Technical Data
						
											
										
							
										Reference
						
											
										
							
										RFQ
						
									
							
							
							Product Overview
			
						
									Chemical Name : (S)-N-(3-(7,8-Dimethoxy-2-oxo-1,2,4,5-tetrahydro-3H-benzo[d]azepin-3-yl)propyl)-N-((3,4-dimethoxybicyclo[4.2.0]octa-1(6),2,4-trien-7-yl)methyl)nitrous amide								
				
									Smiles : COC1=C(OC)C=C(CC(N(CCCN(N=O)C[C@@H]2C(C=C(OC)C(OC)=C3)=C3C2)CC4)=O)C4=C1								
				
									Inchi : InChI=1S/C15H22FN3O6.ClH/c1-3-4-5-6-24-15(23)18-12-9(16)7-19(14(22)17-12)13-11(21)10(20)8(2)25-13;/h7-8,10-11,13,20-21H,3-6H2,1-2H3,(H,17,18,22,23);1H/t8-,10-,11-,13-;/m1./s1								
				
							
							
							Technical Data
			
						
							
							
							Reference
			
						Forced Degradation Studies of Ivabradine and In Silico Toxicology Predictions for Its New Designated Impurities
									Piotr Pikul,1 Marzena Jamru00f3giewicz,1,* Joanna Nowakowska,1 Weronika Hewelt-Belka,2,3 and Krzesimir CiuranFront Pharmacol. 2016; 7: 117.								
				Simultaneous determination of chiral and achiral impurities of ivabradine on a cellulose tris(3-chloro-4-methylphenylcarbamate) chiral column using polar organic mode
									 Joanna Nowakowska,1 Weronika Hewelt-Belka,2,3 and Krzesimir Ciura – Front Pharmacol. 2016; 7: 117. 								
				Characterization of degradation products of Ivabradine by LC-HR-MS/MS: a typical case of exhibition of different degradation behaviour in HCl and H2SO4 acid hydrolysis
									ElekFerenczabBélaKovácsabFranciscBodaaMohammadhassanForoughbakhshfasaeicÉva KatalinKelemenbGerg?TóthcZoltán-IstvánSzabó – Journal of Pharmaceutical and Biomedical Analysis Volume 177, 5 January 2020, 112851 								
				
							
							
							RFQ
			
						
 
                             
                             
                             
                             
                            